From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA approves a new immune-stimulating drug to treat multiple myeloma

from ModernMedicine

FDA has approved elotuzumab as combination therapy with lenalidomide and dexamethasone in people with multiple myeloma who have received one to three prior medications. Multiple myeloma is a hematologic cancer that forms in plasma cells, a type of white blood cell found in the bone marrow that produces antibodies to help fight infections. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063